CapsoVision, Inc. Common Stock (CV) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.580x

Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has a cash flow conversion efficiency ratio of -0.580x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.69 Million) by net assets ($13.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of CapsoVision, Inc. Common Stock to measure how much of total assets are equity-financed.

CapsoVision, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)

This chart illustrates how CapsoVision, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore CapsoVision, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

CapsoVision, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Interarch Building Products Limited
NSE:INTERARCH
0.048x
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
N/A
Hoasen Group
VN:HSG
-0.084x
Tien Phong Securities Corp
VN:ORS
-0.314x
Santana Minerals Ltd
AU:SMI
-0.008x
Guangdong Anjubao Digital Tech
SHE:300155
0.000x
Asia Aviation Public Company Limited
F:55AA
0.100x
Wonderla Holidays Limited
NSE:WONDERLA
0.024x

Annual Cash Flow Conversion Efficiency for CapsoVision, Inc. Common Stock (2023–2025)

The table below shows the annual cash flow conversion efficiency of CapsoVision, Inc. Common Stock from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see CV company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $13.26 Million $-22.86 Million -1.724x -1211.50%
2024-12-31 $-129.51 Million $-20.09 Million 0.155x +57.75%
2023-12-31 $-109.84 Million $-10.80 Million 0.098x --

About CapsoVision, Inc. Common Stock

NASDAQ:CV USA Medical Devices
Market Cap
$328.01 Million
Market Cap Rank
#14231 Global
#3384 in USA
Share Price
$6.58
Change (1 day)
-1.79%
52-Week Range
$3.56 - $14.42
All Time High
$14.42
About

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more